CD8A and COVID-19: Moreover, the trend of reduction in the CD4/CD8 ratio that was found in the EVs of COVID-19 patients with severe disease was also demonstrated in studies that described the changes in the peripheral lymphocytes and inflammatory cytokines in COVID-19 patients in general [50].